|
|
| | 5FMDMB-2201 Basic information |
| Product Name: | 5FMDMB-2201 | | Synonyms: | 5FMDMB-2201;MDDPV;5F-MDMB-2201 Research Chemical Powders;High pure 5fmdmb2201 5f-mdmb-2201 replace 5fadb 5f-adb yellow powder research chemical;5FMDMB2201/5fmdmb2201/4fadb/4f-adb/cannabinoids/mdmb2201 ava(at)hkchemlab.com;5fmdmb2201,4fADB,bmdp,Ebk,Eu,BU,CDC,NDH,Hep,mmb2201 mmbfub, fub2201, 4BB22, MMB022;ight yello powder;Best 5F-mdmb-2201 powder 5fmdmb2201 | | CAS: | 1971007-88-1 | | MF: | C21H29FN2O3 | | MW: | 376.46 | | EINECS: | | | Product Categories: | organic pharmaceutical intermediates;Pharmaceutical;research chemical;medical intermediate;pharmaceutical intermediates;Chemical and pharmaceutical intermediates;Medical research;organic interme;intermediate;5f-mdmb-2201 | | Mol File: | 1971007-88-1.mol |  |
| | 5FMDMB-2201 Chemical Properties |
| Boiling point | 556.8±40.0 °C(Predicted) | | density | 1.12±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | Chloroform (Slightly), Methanol (Slightly) | | pka | 13.25±0.46(Predicted) | | form | Solid | | color | White to Off-White |
| WGK Germany | WGK 2 | | Storage Class | 3 - Flammable liquids | | Hazard Classifications | Acute Tox. 4 Dermal
Acute Tox. 4 Inhalation
Acute Tox. 4 Oral
Eye Irrit. 2
Flam. Liq. 2 | | DEA Controlled Substances | CSCN: 7041
CSA SCH: Schedule I
NARC: No |
| | 5FMDMB-2201 Usage And Synthesis |
| Description | 5-fluoro MDMB-PICA (Item No. 20803) is an analytical reference standard categorized as a synthetic cannabinoid. 5-fluoro MDMB-PICA is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications. | | Uses | 5FMDMB-2201 is a design drug chemical. | | References | [1] SAMUEL D. BANISTER. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues[J]. ACS Chemical Neuroscience, 2016, 7 9: 1241-1254. DOI: 10.1021/acschemneuro.6b00137 |
| | 5FMDMB-2201 Preparation Products And Raw materials |
|